PetLife Pharmaceuticals, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-08-17: Reporting owner Salvagno Ralph T; Form 4; Security Series A Preferred Stock; Transaction J Other acquisition or disposition (describe transaction).
- 2017-08-17: Reporting owner Campbell Vyvyan; Form 4; Security Series A Preferred Stock; Transaction J Other acquisition or disposition (describe transaction).
- 2017-08-17: Reporting owner Vivek Ramana; Form 4; Security Series A Preferred Stock; Transaction J Other acquisition or disposition (describe transaction).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-08-17 | Salvagno Ralph T Director, Officer (Chief Executive Officer), 10% Owner | 4 | Series A Preferred Stock Non-derivative · Indirect · By Grand Street Ventures, LLC | J Other acquisition or disposition (describe transaction) | +1,250,000 1,250,000 owned after | no price filed | 2018-03-02 | |
| 2017-08-17 | Campbell Vyvyan Director | 4 | Series A Preferred Stock Non-derivative · Direct | J Other acquisition or disposition (describe transaction) | +1,000,000 1,000,000 owned after | no price filed | 2018-03-02 | |
| 2017-08-17 | Vivek Ramana Officer (Chief Medical Officer) | 4 | Series A Preferred Stock Non-derivative · Direct | J Other acquisition or disposition (describe transaction) | +1,000,000 1,000,000 owned after | no price filed | 2018-03-02 |